AbCellera Biologics Inc.
看多

ABCL - +40% upside with 1:3 RR

355
Set-up nicely after a squeeze for a breakout and a mean reversion to the fibonacci retracement areas.

My target is 0.50 which is $4.24

However, based on analyst ratings the stock could do 400% in the next 12 months.

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。